How Much Did Brassica Raise?
Funding & Key Investors

Brassica has successfully secured a significant capital injection, bringing its total funding to $2.4M. This latest infusion of $2.4M marks a pivotal moment for the organization as it seeks to solidify its market position within the competitive landscape of functional food ingredients. By leveraging this strategic investment, the company is well-positioned to accelerate its research and development initiatives, further cementing its reputation as a leader in the extraction and commercialization of high-value nutritional compounds.

What is Brassica?

Brassica
Business ServicesResearch & DevelopmentHealth & Nutrition Products

Brassica Protection Products LLC operates at the intersection of biotechnology and consumer health, specializing in the development of nutritional ingredients derived from cruciferous vegetables. The company is best known for its proprietary TrueBroc brand, which provides high-quality glucoraphanin extracted from broccoli seeds. This compound is a precursor to sulforaphane, a molecule widely recognized in scientific literature for its potential health-promoting properties. By supplying these ingredients to dietary supplement manufacturers and the broader food and beverage industry, Brassica serves as a critical link in the supply chain for health-conscious product development. Their commitment to rigorous scientific collaboration ensures that their offerings remain at the forefront of nutritional science, catering to an increasing global demand for evidence-based functional foods.

How much funding has Brassica raised?

Brassica has raised a total of $2.4M across 1 funding round:

2013

Private Equity

$2.4M

Private Equity (2013): $2.4M, investors not publicly disclosed

Key Investors in Brassica

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Brassica?

With this major strategic investment, Brassica is poised to scale its operations and expand its reach within the global nutraceutical market. The company is expected to prioritize the expansion of its TrueBroc product line while deepening its investment in clinical research to validate the efficacy of its core ingredients. As the functional food sector continues to experience rapid growth, Brassica's focus on high-purity, science-backed ingredients will likely attract further interest from both institutional investors and strategic partners. The firm is currently transitioning from a research-heavy development phase into a more aggressive commercial scaling stage, aiming to integrate its proprietary ingredients into a wider array of consumer-facing health products. Future growth will likely be driven by increased penetration into the beverage and premium food sectors, where consumer demand for natural, health-optimizing additives remains at an all-time high.

See full Brassica company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesField Service Management
Business ServicesFood ServiceConvenience Stores, Gas Stations & Liquor StoresRetail
Business ServicesCommercial Printing
Advertising NetworksBusiness Services

Frequently Asked Questions Regarding Brassica Financial Insights

What are the most recent funding rounds that Brassica has completed, and what were the funding rounds?
Brassica has recently completed 1 funding rounds: Private Equity on May 19, 2013.
What is the total amount of funding Brassica has raised to date?
Brassica has raised a total of $2.4M in funding to date.
How many funding rounds has Brassica completed?
Brassica has completed 1 funding rounds.
How much funding did Brassica raise in its most recent funding round?
Brassica raised $2.4M in its most recent funding round.
Which was the largest funding round in Brassica's history?
The largest funding round in Brassica's history was $2.4M.
See more information about Brassica